Valuation: Ha Tay Pharmaceutical

Market Cap 4,822B 188M 170M 157M 142M 268M 17.65B 276M 1.88B 748M 9.44B 705M 690M 30.04B P/E 2024
109x
P/E 2025 109x
Enterprise Value 4,921B 192M 173M 160M 145M 273M 18.02B 281M 1.92B 763M 9.63B 719M 704M 30.66B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+0.21%
1 week-3.01%
Current month-3.20%
1 month-3.78%
3 months-5.44%
6 months-22.84%
Current year-23.94%
1 week 47,600
Extreme 47600.00000000
50,000
1 month 46,600
Extreme 46600
52,000
Current year 46,600
Extreme 46600
68,909.09
1 year 46,600
Extreme 46600
75,000
3 years 17,190.08
Extreme 17190.082644
91,652.89
5 years 10,891.38
Extreme 10891.381343
91,652.89
10 years 4,472.11
Extreme 4472.111908
91,652.89
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-3.01%-31.21%+151.35% 188M
-0.70%+4.58%+40.23%+138.79% 1,271B
+1.11%+4.11%+45.85%+92.54% 683B
-0.18%+2.15%+26.25%+112.46% 520B
-0.77%+3.43%+39.25%+69.09% 389B
-0.16%+0.01%+60.69%+44.94% 362B
-0.20%+0.81%+26.88%+58.54% 304B
+0.01%+0.19%+3.42%+36.18% 286B
-0.22%+1.47%+38.89%+74.73% 253B
-1.05%+0.23%+36.10%+121.22% 208B
Average +0.01%+1.44%+28.64%+89.98% 428B
Weighted average by Cap. +0.12%+2.67%+37.38%+96.71%

Financials

2024 2025
Net sales 2,086B 81.25M 73.48M 67.82M 61.39M 116M 7.64B 119M 814M 324M 4.08B 305M 298M 13B 2,402B 93.55M 84.6M 78.09M 70.68M 133M 8.79B 137M 937M 372M 4.7B 351M 344M 14.96B
Net income 71.77B 2.8M 2.53M 2.33M 2.11M 3.99M 263M 4.1M 28.01M 11.13M 140M 10.49M 10.27M 447M 53.66B 2.09M 1.89M 1.74M 1.58M 2.98M 196M 3.07M 20.94M 8.32M 105M 7.84M 7.68M 334M
Net Debt 290B 11.29M 10.21M 9.42M 8.53M 16.1M 1.06B 16.58M 113M 44.96M 567M 42.38M 41.47M 1.81B 98.73B 3.84M 3.48M 3.21M 2.91M 5.48M 361M 5.65M 38.52M 15.31M 193M 14.43M 14.12M 615M
Projected Income Statement - Annual - Ha Tay Pharmaceutical
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
12/11/26 VND 48,400.00 +0.21% 624
11/11/26 VND 48,300.00 -1.23% 1,600
10/11/26 VND 48,900.00 -2.20% 1,901
09/11/26 VND 50,000.00 +2.04% 1,032
06/11/26 VND 49,000.00 -1.80% 1,048